Patents Examined by Joanne Giesser
  • Patent number: 4673646
    Abstract: This invention provides a process for the bioconversion of a non-growth aromatic feed to an accumulated quantity of 2-hydroxymuconic semialdehyde metabolite.2-Hydroxysemialdehyde is a useful intermediate for subsequent conversions to picolinic acid and pyridine.
    Type: Grant
    Filed: August 12, 1985
    Date of Patent: June 16, 1987
    Assignee: Celanese Corporation
    Inventor: Scott Hagedorn
  • Patent number: 4666841
    Abstract: This invention provides a process for the bioconversion of a non-growth aromatic feed to an accumulated quantity of a 2-hydroxymuconic semialdehyde intermediate, which subsequently is converted by chemical means to picolinic acid and pyridine products.
    Type: Grant
    Filed: May 7, 1984
    Date of Patent: May 19, 1987
    Assignee: Celanese Corporation
    Inventor: Scott Hagedorn
  • Patent number: 4624922
    Abstract: A novel plasmid pCX311, which was constructed from Bacillus sp. C125 chromosomal DNA carrying the gene for extracellular production of xylanase and a vector plasmid pBR322. A novel microorganism, Escherichia coli HB101 (pCX311) carrying the plasmid pCX311 and being capable of extracellular production of xylanase. Method for culturing the microorganism characterized by cultivation of it in the medium containing NaCl (or KCl) and bran, or NaCl (or KCl) and xylan for 12-48 hours. According to this invention, useful high-molecular substances can be produced in a high yield.
    Type: Grant
    Filed: March 19, 1984
    Date of Patent: November 25, 1986
    Assignee: Rikagaku Kenkyusho
    Inventors: Koki Horikoshi, Toshiaki Kudo, Hiroshi Honda
  • Patent number: 4554249
    Abstract: A novel enzyme of bilirubin oxidase produced by a genus Myrothecium or genus Coprinus origin microorganism and a conventional enzyme of laccase are found, in the presence of a specific additive compound, e.g. a surface active agent, aromatic carboxylic acid, sulfa drug or protease, to oxidize both conjugated and unconjugated bilirubin in biological fluid to biliverdin without formation of hydrogen peroxide, such that in the case of conventional enzymatic methods of the quantitative determination of glucose, cholesterol, neutral fats, free fatty acids, phospholipids or uric acid all existing together with bilirubin in biological fluid, the usual interference with such determination, as otherwise caused by bilirubin coexisting in such fluid, can be prevented by adding such a bilirubin oxidase or laccase together with such a specific additive compound to the determinative reaction system.
    Type: Grant
    Filed: October 25, 1982
    Date of Patent: November 19, 1985
    Assignee: Amano Pharmaceutical Company Limited
    Inventors: Akira Kosaka, Sawao Murao, Kenichi Hirano, Noriaki Tanaka, Kuniyoshi Matsunaga
  • Patent number: 4533628
    Abstract: In the colony hybridization technique, bacterial colonies are replica-plated onto filter paper, and their DNA is hybridized with labeled DNA containing a specific sequence. A one-hundred fold increase in sensitivity is obtained by subjecting the colonies to a stream of steam in the presence of alkali for about three minutes prior to hybridization.
    Type: Grant
    Filed: August 3, 1983
    Date of Patent: August 6, 1985
    Assignee: New York University
    Inventor: Renata Maas